Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes

Clinical and Experimental Immunology

Volumn 146, Issue 1, 2006, Pages 9-14

  Hall, T R ^a   Thomas, J W ^d   Padoa, C J ^b   Torn, C ^e   Landin Olsson, M ^e   Ortqvist, E ^c   Hampe, C S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c KAROLINSKA INSTITUTE   (Sweden)

^d VANDERBILT UNIVERSITY   (United States)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epitopes; Insulin autoantibody; Radioligand binding assay; Recombinant Fab; Type 1 diabetes

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; INSULIN ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AE9D6; MONOCLONAL ANTIBODY CG7C7; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING, COMPETITIVE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EPITOPES; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN FAB FRAGMENTS; INSULIN; INSULIN ANTIBODIES; LONGITUDINAL STUDIES; RECOMBINANT PROTEINS;

EID: 33748688064     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03178.x     Document Type: Article

References (33)

1. Notkins AL, Lernmark Å. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001; 108:1247-52.
2. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85:291-7.
3. Bingley PJ, Christie MR, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:1304-10.
4. Kulmala P, Savola K, Reijonen H et al. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes Finland Study Group. Diabetes 2000; 49:48-58.
5. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes. the 2-year analysis of the German BABYDIAB Study. Diabetes 1999; 48:460-8.
6. Vardi P, Keller R, Dib S, Eisenbarth GS, Soeldner JS. Log-linear correlation of CIAA with age in new onset type I diabetics. Diabetes 1988; 37:28A.
7. Roll U, Christie MR, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 1996; 45:967-73.
8. Naserke HE, Bonifacio E, Ziegler AG. Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 2001; 86:4826-33.
9. Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract 1994; 24 (Suppl.):S153-7.
10. Wilkin T, Armitage M, Casey C et al. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1985, 480-2.
11. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with Type 1 diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313:462-4.
12. EURODIAB. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 2000; 41:47-53.
13. Pundziute-Lycka A, Dahlquist G, Nystrom L et al. Type I diabetes in the 0-34 years group in Sweden. Diabetologia 2002; 45:783-91.
14. Weets I, Siraux V, Daubresse JC et al. Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab 2002; 87:2597-605.
15. Hoppu S, Ronkainen MS, Kimpimaki T et al. Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes. Pediatr Res 2004; 55:236-42.
16. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro) insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114:589-97.
17. Davis SN, Thompson CJ, Peak M, Brown MD, Alberti KG. Effects of human insulin on insulin binding antibody production in nondiabetic subjects. Diabetes Care 1992; 15:124-6.
18. Devendra D, Galloway TS, Horton SJ, Evenden A, Keller U, Wilkin TJ. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes. Diabetologia 2003; 46:802-9.
19. Diaz JL, Wilkin T. Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 1987; 36:66-72.
20. Mirza IH, Wilkin TJ. Antigenicity of the carboxyl terminus of insulin: isolation of human insulin-specific monoclonal antibodies. Immunology 1988; 65:43-6.
21. Padoa CJ, Crowther NJ, Thomas JW et al. Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol 2005; 140:564-71.
22. Padoa CJ, Banga JP, Madec AM et al. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 2003; 52:2689-95.
23. Gilliam LK, Binder KA, Banga JP et al. Multiplicity of the antibody response to GAD65 in Type I diabetes. Clin Exp Immunol 2004; 138:337-41.
24. Schroer JA, Bender T, Feldmann RJ, Kim KJ. Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol 1983; 13:693-700.
25. Rojas M, Hulbert C, Thomas JW. Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J Immunol 2001; 166:3194-200.
26. Carter P, Kelley RF, Rodrigues ML et al. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology 1992; 10:163-7.
27. Neidhardt FC, Bloch PL, Smith DF. Culture medium for enterobacteria. J Bacteriol 1974; 119:736-47.
28. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM. A novel micro-assay for insulin autoantibodies. J Autoimmunity 1997; 10:473-8.
29. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52:1128-36.
30. Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 2005; 54 (Suppl. 2):S52-61.
31. Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS. Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 1993; 42:1202-9.
32. Brooks-Worrell BM, Nielson D, Palmer JP. Insulin autoantibodies and insulin antibodies have similar binding characteristics. Proc Assoc Am Physicians 1999; 111:92-6.
33. Fineberg SE, Kawabata T, Finco-Kent D, Liu C, Krasner A. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. J Clin Endocrinol Metab 2005; 90:3287-94.